Airways responsiveness and development and remission of chronic respiratory symptoms in adults

Lancet

Volumn 350, Issue 9089, 1997, Pages 1431-1434

  Xu, Xiping ^a   Rijcken, Bert ^c   Schouten, Jan P ^c   Weiss, Scott T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CHANNING LABORATORY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COUGHING; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; REMISSION; RESPIRATORY TRACT DISEASE; RISK; SYMPTOM; WHEEZING;

EID: 0031583731     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)10041-1     Document Type: Article

References (28)

1. One NGM, Sluiter HJ, deVries K, Tammeling GJ, Witkop J. The host factor in bronchitis. In: Orie NGM, Sluiter HJ, eds. Bronchitis: an international symposium. Assen, Netherlands: Royal van Gorcum, 1961: 44-59.
2. Jeffrey PK, Goddrey RW, Adelroth E, Melson F, Rogers A, Bhan Scan SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular degree in asthma. Am Rev Respir Dis 1992; 145: 890-99.
3. van der Lende R. Epidemiology of chronic non-specific lung disease (chronic bronchitis). Thesis. Assen, Netherlands: Royal van Gorcum, 1969.
4. 1 with time: indicators for effects of smoking and air pollution. Bull Eur Physiopathol Respir 1981; 17: 775-92.
5. Rijcken B, Schouten JP, Weiss ST, Speizer FE, van der Lende R. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. Am Rev Respir Dis 1987; 136: 62-68.
6. Rijcken B, Schouten JP, Weiss ST, Meinesz AF, deVries K, van der Lende R. The distribution of bronchial responsiveness to histamine in symptomatic and in asymptomatic subjects. Am Rev Respir Dis 1989; 140: 615-23.
7. Rijcken B, Schouten JP, Weiss ST, Speizer FE, van der Lende R. The relationship between airway responsiveness to histamine and pulmonary functions level in a random population sample. Am Rev Respir Dis 1988; 137: 826-32.
8. Xu X, Laird N, Dockery DW, Schouten JP, Rijcken B, Weiss ST. Age, period and cohort effects on pulmonary function in a 24-year longitudinal study. Am J Epidemiol 1995; 141: 554-66.
9. Xu X, Weiss ST, Rijcken B, Schouten JP. Association of smoking and changes in smoking habits with rate of loss of FEV1 : a new insight into gender differences. Eur Respir J 1994; 7: 1056-61.
10. Xu X, Weiss ST, Dockery DW, Schouten JP, Rijcken B. Comparing FEV1 in adults in two community based studies. Chest 1995; 108: 656-62.
11. deVries K, Goei JT, Booy-Noord H, Orie NGM. Changes during 24 hours in the lung function and histamine hyperactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy 1962; 20: 93-101.
12. Eiser NM, Kerrebijn KF, Quanjer PH. Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents. Bull Eur Physiopathol Respir 1983; 19: 495-514.
13. Helsing JK, Comstock GW, Speizer FE, et al. Comparison of three standardized questionnaires on respiratory symptoms. Am Rev Respir Dis 1979; 120: 1221-31.
14. van der Lende R, Orie NGM. The MRC-ECCS questionnaire on respiratory symptoms (use in epidemiology). Scand J Respir Dis 1972; 53: 218-26.
15. van der Lende R, van der Meulen GG, Wever-Hess J. Investigation into observer and seasonal variation of the prevalences of respiratory symptoms at Schiermonnikoog. Int J Epidemiol 1972; 1: 47-50.
16. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
17. Lefkopoulou M, Moore D, Ryan L. The analysis of multiple correlated binary outcomes: application to rodent teratology experiments. J Am Stat Assoc 1989; 84: 810-15.
18. McCullagh P, Nelder JA. Generalized linear model: Quali-likelihood functions. London: Chapman and Hall, 1989.
19. Xu X, Zhao L, Neas L, Dockery D, Ware J. Multiple response modeling of respiratory symptom variables: effect of household smoking status on multiple lower respiratory symptoms in children. Am Rev Respir Dis 1991; 143: A90 (abstr).
20. Sparrow D, O'Connor G, Colton T, Barry CL, Weiss ST. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symtoms and decreased levels of pulmonary function. Am Rev Respir Dis 1987; 135: 1255-60.
21. Woolcock AJ, Peat JK, Salome CL, et al. Prevalence of bronchial hyper responsiveness and asthma in a rural adult population. Thorax 1987; 42: 361-68.
22. Burney CGJ, Britton JR, Chinn S, et al. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 1987; 42: 38-44.
23. Pham QT, Mur JM, Chan N, Gabiano M, Henquel JC, Teculescu D. Prognostic value of acetylcholine challenge test: a prospective study. Br J Ind Med 1984; 41: 267-71.
24. Frew AF, Kennedy SM, Chan-Yeung M. Methacholine responsiveness, smoking, and atopy as risk factors for accelerated FEV1 decline in male working populations. Am Rev Respir Dis 1992; 146: 878-83.
25. Wardlaw AJ, Dannette S, Gleich GJ, Collons JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperactivity. Am Rev Respir Dis 1988; 137: 62-69.
26. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-37.
27. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthmatic subjects. Am Rev Respir Dis 1990; 142: 1407-13.
28. Taylor KJ, Luksza AR. Peripheral blood eosinophilia and bronchial responsiveness. Thorax 1987; 42: 452-56.